The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 22, 2022

Filed:

Jan. 18, 2019
Applicant:

Syneurx International (Taiwan) Corp., New Taipei, TW;

Inventors:

Guochuan Emil Tsai, Pasadena, CA (US);

Ching-Hsun Huang, Taipei, TW;

Han-Yi Hsieh, New Taipei, TW;

Jing-Jia Huang, New Taipei, TW;

Ching-Cheng Wang, New Taipei, TW;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 45/06 (2006.01); A61K 31/12 (2006.01); A61K 31/5415 (2006.01); A61K 31/382 (2006.01); A61K 31/5513 (2006.01); A61K 31/519 (2006.01); A61K 31/554 (2006.01); A61K 31/496 (2006.01); A61K 31/40 (2006.01); A61K 31/407 (2006.01); A61K 31/4439 (2006.01); A23L 33/16 (2016.01); A23L 33/00 (2016.01); A61K 33/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A23L 33/16 (2016.08); A23L 33/30 (2016.08); A61K 31/12 (2013.01); A61K 31/382 (2013.01); A61K 31/40 (2013.01); A61K 31/407 (2013.01); A61K 31/4439 (2013.01); A61K 31/496 (2013.01); A61K 31/519 (2013.01); A61K 31/5415 (2013.01); A61K 31/554 (2013.01); A61K 31/5513 (2013.01); A61K 33/00 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01);
Abstract

The present invention relates to a composition comprising a lithium salt of an N-substituted glycine compound and a carrier, wherein the lithium salt of the N-substituted glycine compound is of Formula (I): in which R, R, and Reach are independently hydrogen, alkyl, alkenyl, alkynyl, aralkyl, carbocyclyl, aryl, or heteroaryl, or one of R, R, and Ris absent. Also provided in the present invention is a method of mitigating at least one symptom of a neuropsychiatric disorder, comprising administering to a subject in need thereof the lithium salt of an N-substituted glycine compound of Formula (I).


Find Patent Forward Citations

Loading…